L 722151
| Code | Size | Price |
|---|
| TAR-T24349-5mg | 5mg | £1,167.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
L 722151 is an FXIIIa inhibitor.
CAS:
122841-09-2
Formula:
C8H9ClN2O5S3
Molecular Weight:
344.8
Purity:
0.98
SMILES:
[O-][Cl](=O)(=O)=O.CC(=O)CSc1n[n+]2c(C)csc2s1
References
1. Leidy EM, Stern AM, Friedman PA, Bush LR. Enhanced thrombolysis by a factor XIIIa inhibitor in a rabbit model of femoral artery thrombosis. Thromb Res. 1990 Jul 1;59(1):15-26. PubMed PMID: 1975957.
2. Shebuski RJ, Sitko GR, Claremon DA, Baldwin JJ, Remy DC, Stern AM. Inhibition of factor XIIIa in a canine model of coronary thrombosis: effect on reperfusion and acute reocclusion after recombinant tissue-type plasminogen activator. Blood. 1990 Apr 1;75(7):1455-9. PubMed PMID: 1969293.